Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-ranging Study to Examine the Pharmacokinetics, Safety, Tolerability and Efficacy of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain

NCT04976738 is registered in ClinicalTrials.gov with Cymra Life Sciences as lead sponsor.

NCT NCT04976738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-ranging Study to Examine the Pharmacokinetics, Safety, Tolerability and Efficacy of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
Lead sponsor
Cymra Life Sciences
Phase
Phase 1/2
Overall status
Completed
Start date
September 20, 2021
Completion date
June 21, 2022
Enrollment
28 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, cbd, chronic pain, neck pain, pain, pain, back, pain, chronic, pain, neck, thc